Sicilian Administrative Data Base Study in Acute Coronary Syndrome Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Study Classification

OBSERVATIONAL

Study Start Date

2012-09-30

Study Completion Date

2012-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Thi is an observational, non interventional, cohort analysis by using administrative databases (drugs treatment, laboratory and diagnostic tests, specialist visits and hospitalizations) of Sicilia region to evaluate treatment patterns of patients after Acute Coronary Syndrome (ACS) event.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

HEALTH-DB ACS

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Acute Coronary Syndrome Acute Myocardial Infarction

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

ACS AMI

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects discharged alive from hospitalization for ACS

Exclusion Criteria

* All patients that don't have a continuative presence as beneficiaries of the region between January 1st, 2007 and December 31st 2011 will be excluded from analysis.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Flore La Tour

Role: STUDY_CHAIR

AstraZeneca CLINICAL RESEARCH DIRECTOR

Raffaele Sabia

Role: STUDY_DIRECTOR

AstraZeneca Italy - VP MEDICAL

Rosalia Traiana, Doctor of Pharmacology

Role: PRINCIPAL_INVESTIGATOR

Department of Pharmaceutical Health - SICILIAN REGION

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Research Site

Palermo, , Italy

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Italy

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NIS-CIT-XXX-2012/1

Identifier Type: -

Identifier Source: org_study_id